Sort
78,016 grants matching “breast cancer”
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and Recurrence
$454,781William Schiemann · Case Western Reserve University · R01 · FY2020 · CA
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer
$454,774Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
Administrative Core
$454,764Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
Environmental Effect on the Mammary Gland across the Lifespan
$454,762Zena Werb · University Of California, San Francisco · U01 · FY2013 · ES
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
$454,761Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
RENEW Research-out to ENhancE Wellness Older Survivors
$454,753Wendy Demark-Wahnefried · Duke University · R01 · FY2007 · CA
Ultrasound imaging and enhanced therapeutic response
$454,749Katherine W Ferrara · University Of California At Davis · R01 · FY2015 · CA
Cancer Bioinformatics Services
$454,743Riyue Bao · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA
Ponce School of Medicine - Moffitt Cancer Center Partnership
$454,725Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2010 · CA
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
$454,712Karen Champagne Glass · Albany College Of Pharmacy · R01 · FY2018 · GM
Pain, Distress and Mammography Use in Breast Cancer Patients
$454,649Francis J. Keefe · Duke University · R01 · FY2011 · CA
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$454,633Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$454,633Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Sleep, Circadian, Hormonal Dysregulation, and Breast Cancer Survival
$454,590David Spiegel · Stanford University · R01 · FY2007 · CA
Real-time In Vivo MRI Biomarkers for Breast Cancer Pre-operative Treatment Trials
$454,587Nola M. Hylton · University Of California, San Francisco · R01 · FY2011 · CA
Breast Cancer Detection Consortium
$454,587Jeffrey R. Marks · Duke University · U01 · FY2017 · CA
Monitoring Breast Cancer Chemotherapeutic Response Using DOSI, MRI and Biomarkers
$454,567Bruce J Tromberg · University Of California-Irvine · U54 · FY2010 · CA
Outcomes of Older Women with Early Stage Breast Cancer
$454,562Ann B. Nattinger · Medical College Of Wisconsin · R01 · FY2007 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$454,539Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
METABOLIC CONTROL OF DC FATE AND FUNCTION FOR BREAST CANCER IMMUNOTHERAPY
$454,500Saint Louis University · · FY2020 · Department of the Army
Longitudinal Tumor Monitoring with Nanodevices
$454,498Andrew Kummel · University Of California, San Diego · U54 · FY2009 · CA
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio
$454,422Thomas D Wang · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$454,400David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Nipple Fluid Hormone Levels and Breast Cancer Risk
$454,396Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2011 · CA
Immunostimulatory Nanocarrier for Breast Cancer Immunochemotherapy
$454,390Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA